verona pharma
Verona Pharma to share phase 3 COPD trial data at ATS 2024
May 2, 2024Medical Communications COPD, Cardiology, clinical trial, verona pharma
Verona Pharma has announced that it will share eight posters at the American Thoracic Society International Conference (ATS) 2024, including …
Verona Pharma submits FDA New Drug Application for COPD treatment
June 27, 2023Research and Development COPD, Cardiology, FDA, ensifentrine, new drug application, verona pharma
UK-based Verona Pharma has announced that it has submitted a New Drug Application (NDA) to the US Food and Drug …
Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board
March 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma
Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
Verona’s shares drop 34% on Phase 2 failure of nebulised ensifentrine in COPD
January 15, 2019Manufacturing and Production, Research and Development Boehringer, COPD, Stiolto Respimat, pharma, trial failure, verona pharma
Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in …
Verona Pharma loses Chief Medical Officer
April 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma
Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …
Verona Pharma’s respiratory drug proves positive in study
October 1, 2015Research and Development COPD, verona pharma
Verona Pharma has announced encouraging positive headline data of the third and final part of a randomised, clinical study in …
Verona Pharma appoints chief financial officer
October 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roy biresh, verona pharma
London-based drug development firm Verona Pharma has hired Biresh Roy as its chief financial officer and member of the board …
